Investment Pitches

Pitch Summary:
We divested our position in Equifax (EFX) during the quarter following a strategic shift by FICO, a leading provider of credit scores to the mortgage industry. FICO announced plans to sell its credit scores directly to mortgage underwriters, bypassing the credit bureaus and thereby pressuring the economics that EFX has historically captured in the credit-scoring value chain. This change increases uncertainty around the long-term distribution of economics within the mortgage credit ecosystem and widens the range of potential outcomes for EFX. Coupled with a slower-than- expected recovery in the housing market, we believe this evolving industry dynamic has weakened the risk-reward profile of the investment. As a result, we chose to exit the position and redeploy capital into opportunities within the portfolio that offer more attractive return potential with greater visibility.

BSD Analysis:
Equifax’s moat is regulatory entrenchment plus data inertia—credit bureaus are utilities pretending to be tech firms. Once embedded in lending, insurance, and employment workflows, displacement is nearly impossible. The real asset is not the data itself, but permission to use it at scale. Pricing power is quiet but persistent because customers pass costs through rather than fight them. The failure mode is reputational: breaches don’t kill the model, but they permanently cap the multiple. Growth now comes from analytics, verification, and workforce data rather than pure credit cycles. Macro downturns hit volumes, not relevance. Equifax is infrastructure with a trust tax baked into valuation.

Pitch Summary:
Netflix (NFLX) has built a durable economic moat around its vertically-integrated, globally-scaled streaming business. As the first company to establish a global subscription media platform within the $500 billion TV market, Netflix is now reaping the benefits of its early leadership. Its march toward global dominance has been propelled by substantial investments in both technology and content. The broader media industry, meanwhile, is undergoing a structural transformation driven by technology, as the traditional TV bundle fades and legacy media companies scramble to replicate Netflix’s success. However, without global scale, the escalating costs of competing in the content wars are unsustainable. With more than 300 million members, Netflix enjoys the lowest content cost per subscriber in the industry, an advantage that enables it to profitably outspend rivals and accelerate its competitive flywheel. We expect this edge to continue compounding over time. At the time of purchase, Netflix’s stock was down nearly 20% from its February peak. Near-term macroeconomic uncertainty likely contributed to this volatility, creating an attractive entry opportunity. This downward pressure was further intensified by market skepticism surrounding Netflix’s $82.7 billion bid for Warner Bros. Discovery. While the deal promises a massive expansion of premium intellectual property (IP), investors have reacted with caution to the prospect of a bidding war with Paramount Skydance and the operational complexities of such a historic pivot. While we acknowledge these integration risks, we believe the long-term upside significantly outweighs the near-term downside. In our view, the acquisition of iconic franchises like Harry Potter, the DC Universe, and the HBO library represents a generational shift from a "streaming platform" to a "global media powerhouse." We believe the market is over-discounting the strategic moat this IP provides, creating a compelling risk-reward profile for patient investors. With industry-leading profitability, Netflix continues to pull ahead of competitors through disciplined execution, a high-quality content slate, and unmatched scale. Additionally, we believe the company’s ad-supported tier and push into live sports represent significant new growth initiatives. Entering these catalysts from a position of strength—as the global leader in streaming revenue, subscribers, viewing hours, content, and profits—positions Netflix for intrinsic value compounding of approximately 15–20% over our investment horizon.

BSD Analysis:
Netflix is framed as the scale winner in streaming, with 300M+ members driving the lowest content cost per subscriber and a reinforcing competitive flywheel. Near-term volatility is seen as an entry point, even as investors debate the strategic leap implied by the Warner Bros. Discovery bid and integration complexity. The manager views premium IP acquisition as potentially transformative, shifting Netflix toward a broader global media powerhouse. Importantly, Netflix is pursuing new growth vectors—ads and live sports—from a position of profitability and operational discipline. The bull case is sustained share gains as competitors struggle to match global scale economics. Key risks are deal execution, integration distraction, and content spending escalation, but the pitch expects 15–20% intrinsic value compounding driven by moat expansion and new monetization avenues.

Pitch Summary:
Taiwan Semiconductor (TSM) is the dominant manufacturer of semiconductors for the world’s leading fabless chip designers including NVIDIA, Apple, Broadcom, and others. TSM is the world’s preeminent semiconductor foundry due to its leadership position in producing the most advanced chips that power the world’s most sophisticated supercomputers, personal computers, and mobile devices. It is also one of only two manufacturers that operates at the leading edge of semiconductor process technology. This technological leadership, reinforced by scale economies, proprietary process know-how, and decades of accumulated manufacturing expertise, creates a formidable competitive moat that is increasingly difficult for other foundries to replicate. As a result, TSM earns structurally higher gross margins than its peers through a combination of technology-driven pricing power and superior manufacturing efficiency. TSM has also benefited from ongoing consolidation within the semiconductor industry, which has accelerated demand for integrated systems built on the most advanced process nodes. At the same time, the rapid growth of artificial intelligence, high-performance computing, and the Internet of Things is driving sustained demand for leading-edge semiconductors, as computing becomes increasingly intelligent and interconnected. We believe the global arms race to develop artificial general intelligence will support multiple years of robust growth for foundries with true leading-edge capabilities. TSM is uniquely positioned to benefit regardless of which fabless chip architecture ultimately dominates high-performance computing, as its customers span the full spectrum of leading AI, CPU, GPU, and custom accelerator designs. Semiconductor manufacturing is inherently cyclical and capital intensive, yet we believe these factors further strengthen TSM’s moat rather than weaken it. The escalating cost and complexity of advanced-node fabrication requires tens of billions of dollars in sustained annual capital expenditures, which raises the barriers to entry and constrains credible competition. During industry downturns, TSM’s scale, balance sheet strength, and customer entrenchment should allow it to continue investing through the cycle, widening the technology gap versus smaller or less well-capitalized peers. We believe these structural advantages should enable TSM to generate returns on invested capital well above its cost of capital across the business cycle and to compound intrinsic value at rates meaningfully in excess of broader market growth over our investment horizon.

BSD Analysis:
TSMC is pitched as a scarce asset in the AI era: the leading-edge foundry with process leadership, scale economies, and deep manufacturing know-how that is hard to replicate. AI, high-performance computing, and IoT are driving sustained demand for advanced nodes, and consolidation among fabless designers increases reliance on best-in-class foundries. Capital intensity raises barriers to entry, allowing TSMC to keep widening its technology gap through cycles. That moat should support structurally higher margins and ROIC versus peers over time. The key bull driver is that TSMC wins regardless of which fabless architecture dominates, because it manufactures for the leading designers across the ecosystem. Risks include geopolitics, export controls, and the inherent cyclicality of semis, but the pitch emphasizes scale and balance sheet strength as cycle defenses.

Pitch Summary:
While the company remains a high-quality global leader in industrial gases, shares of Linde plc (LIN) declined nearly 10% in Q4 due to a persistent industrial gas volume recession, softer guidance and global macroeconomic concerns. From a macro standpoint, the company continues to struggle with negative base volumes in its core industrial segments. Much of this is attributable to economic stagnation in Europe and suppressed demand in China. While price increases helped offset some costs, they were insufficient to mask the 1-3% volume declines evidenced in these key territories. In response to this weakness, management announced cautious guidance in late October and during subsequent updates in December, causing consensus earnings estimate reductions. These revisions drove P/E multiple contraction as investors rotated out of high-quality, defensive names like Linde into higher growth opportunities in other sectors like technology. Despite the recent dip, we believe much of Linde's woes are transitory in nature and not a breakdown of the business model. The company's $10+ billion backlog, particularly in clean hydrogen and electronics, provides a strong foundation for a long-term growth recovery. We remain holders of the shares of this high-quality, wide moat business in anticipation of a future growth reacceleration.

BSD Analysis:
Linde’s weakness is attributed to a cyclical volume recession and cautious guidance rather than a deterioration of its moat. Europe stagnation and softer China demand are weighing on base volumes, prompting estimate cuts and multiple contraction. The counterweight is a $10B+ backlog—especially in clean hydrogen and electronics—that can reaccelerate growth as projects convert. Linde’s pricing discipline and structural barriers in industrial gases support resilient mid-cycle economics. The thesis is bullish on mean reversion: when industrial activity normalizes, earnings and multiple can recover. Risks are a prolonged volume recession or delayed hydrogen/electronics project timing. Overall, the manager is leaning into quality at a temporarily depressed sentiment point.

Pitch Summary:
Microsoft’s (MSFT) stock came under pressure in Q4 as investors grew concerned about the rising cost of building AI data infrastructure to support foundation models such as OpenAI. Capital expenditures across Microsoft and its hyperscaler peers accelerated in calendar 2025 and are expected to increase again in 2026. While these investments are substantial, Microsoft is well positioned to fund this growth through its large and expanding base of operating cash flows. That said, the company does have meaningful exposure to OpenAI, which remains relatively unproven given the scale and duration of its contractual commitments. We continue to maintain Microsoft as a top holding, as we believe the company’s financial strength, diversified revenue streams, and broad customer base provide significant resilience. Microsoft is seeing accelerating growth within Azure, its hyperscale cloud platform which remains capacity- constrained, alongside increasing adoption of its Copilot offerings across its extensive enterprise customer base. We believe Microsoft should be well positioned to generate attractive long-term returns from its partnership with OpenAI and to effectively monetize generative AI capabilities across its global enterprise IT footprint through its expanding suite of Copilot and AI-enabled products.

BSD Analysis:
Microsoft’s drawdown is tied to investor anxiety over AI infrastructure capex, but the bull case is that few companies can self-fund this investment as comfortably. Azure’s growth and capacity constraints point to strong underlying demand, and Copilot adoption provides a clear, high-ARPU monetization lever across the enterprise base. OpenAI exposure is acknowledged as a risk, yet also a strategic advantage that can accelerate product leadership and customer pull-through. The near-term tradeoff is margin pressure versus building a longer-duration AI moat and expanding cloud share. The pitch stays bullish because Microsoft has diversified revenue, sticky customers, and the cash-flow engine to compound through investment cycles. Key watch items are capex efficiency and the pace of Copilot monetization.

Pitch Summary:
Investor enthusiasm for Oracle’s (ORCL) stock in calendar year 2025 was initially driven by several multi-billion-dollar contracts it signed with leading AI companies, including OpenAI and Meta. However, in Q4 sentiment for ORCL’s growth prospects shifted to skepticism, as investors began to scrutinize the return profile of the substantial capital investments required to support the approximately $500 billion of contracts signed by Oracle. As a result, investors grew increasingly concerned about Oracle’s ability to fund these investments and the concentration of future revenue exposure tied to OpenAI. While OpenAI is an early leader in artificial intelligence with nearly 900 million weekly average users, it remains relatively unproven given the scale and duration of its contractual commitments. We recognize the risks associated with OpenAI’s ability to fund these obligations and to successfully monetize its platform beyond consumer subscriptions, including through advertising and deeper penetration of the enterprise IT market. Given the widening range of potential outcomes associated with Oracle’s elevated capital needs, we reduced our position in ORCL during Q4. We continue to maintain a smaller weighting, as we believe Oracle is capable of managing its capital requirements and generating attractive long-term returns from these investments.

BSD Analysis:
Oracle’s AI contract momentum created a powerful demand narrative, but the manager’s core concern is the capital intensity required to fulfill enormous commitments and the uncertain return profile. Concentration—especially dependence on OpenAI-linked demand—widens the distribution of outcomes if counterparties or monetization falter. The trim reflects this ROIC dispersion risk, not an outright rejection of Oracle’s strategic positioning in cloud infrastructure. If Oracle can fund build-out without sacrificing balance-sheet flexibility, the embedded contract value could translate into durable cash flows. However, the bear case is that capital needs and counterparty risk compress returns and increase funding uncertainty. The stance is cautious: participate with reduced sizing, demanding clearer visibility into economics.

Pitch Summary:
After lagging through the first three quarters of 2025, Danaher’s (DHR) stock rebounded during Q4 as bioprocessing, life science, and diagnostics demand continued to recover from a cyclical trough. On the 3Q25 call, management established conservative 2026 growth expectations. Revenue is expected to continue to lag long-term trends at 3-6% but improve throughout the year. Operating leverage should drive high single digit EPS growth. The company’s strong balance sheet and capital deployment strategy should provide accretive growth for the foreseeable future.

BSD Analysis:
Danaher is presented as a high-quality platform exiting a cyclical trough, with bioprocessing, life science, and diagnostics demand recovering. Management’s conservative 2026 view still implies improving revenue cadence through the year, and operating leverage should convert that into high single-digit EPS growth. Danaher’s balance sheet and proven capital deployment add a second engine—accretive M&A—to sustain long-run compounding. The setup is attractive if customer destocking truly normalizes and bioprocessing utilization improves. Key risks are a slower recovery, renewed budget pressure in life science tools, or weaker-than-expected operating leverage. The pitch is fundamentally bullish on the platform and on-cycle reinvestment discipline.

Pitch Summary:
Johnson & Johnson (JNJ) stock demonstrated strong performance in Q4, driven by robust financial results, upward guidance revisions, and accelerating growth for the pharmaceutical and medical technology segments. The company's consistent execution across key business segments and positive market sentiment, despite a significant headwind from Stelara generics, contributed to its outperformance relative to broader market indices. Management continues to expect 5-7% revenue growth through 2030 which exceeds consensus estimates.

BSD Analysis:
J&J’s moat is diversification across pharma, devices, and consumer health—now more focused post spin-offs. Scale and balance sheet strength provide resilience through cycles. Pharma drives growth, devices provide stability. Litigation is a recurring tax, not a surprise. Capital allocation discipline matters more than breakthrough innovation. The failure mode is pipeline disappointment coinciding with legal costs. The bull case is steady compounding with defensive characteristics. J&J is reliability packaged as equity.

Pitch Summary:
Alphabet’s (GOOG) Q4 performance marks a significant triumph, characterized by a rare “beat and raise” narrative across all critical business segments. The company’s recent earnings report was driven by a balanced contribution from its legacy Search and YouTube divisions, with Google Cloud emerging as the standout performer. Cloud’s revenue growth reached an impressive 34%, and it boasts an extraordinary $155 billion backlog, a nearly double increase compared to the previous quarter. This remarkable transformation has propelled Cloud from a margin drag to a high-octane profit center. Operational leverage indicates that Alphabet is successfully scaling its infrastructure while maintaining disciplined cost controls. Strategically, the “AI-first” pivot has transcended its initial roadmap status and become a tangible driver of user engagement and enterprise spending. The milestone of 650 million monthly active users on the Gemini App serves as a tangible counter-narrative to concerns about AI-driven search disruption. By integrating Gemini across its entire ecosystem, Alphabet has fortified its competitive advantage, enabling it to defend its search franchise while simultaneously capturing new market share in the enterprise cloud sector. This fundamental strength underpins a trajectory of high-teens EPS growth, making a 20x–25x earnings multiple appear conservative despite the stock’s recent appreciation.

BSD Analysis:
Alphabet remains a dominant cash generator, but AI has introduced real monetization uncertainty. The moat is distribution—Search defaults, Android, YouTube—not model leadership. AI answers threaten ad density even if engagement rises. Cloud diversifies revenue but consumes capital. Regulation caps multiples without killing cash flow. Execution must balance innovation with cannibalization. The bull case is successful AI monetization layered onto scale. Alphabet wins if it evolves without breaking the machine.

Pitch Summary:
Vistry is our U.K. asset light “Partnerships” homebuilder. The business is recession resilient and actively repurchasing stock after being punished for legacy accounting issues. The U.K. government has announced a new ten-year £39B housing funding program that should drive multi-year growth. Management expects EBIT growth of more than 20% in 2026 with a significant step-up in 2027. Despite this, shares trade at roughly 4.5x forward EBIT.

BSD Analysis:
Vistry is a UK homebuilder exposed to interest rates, affordability, and policy. The moat is land bank quality and execution discipline, not brand. Partnerships and affordable housing add resilience but cap margins. Cash flow is cyclical by nature. The failure mode is rate shocks stalling completions. The bull case is housing normalization and policy support. Vistry is a cycle participant, not a secular compounder. Timing drives returns.

Pitch Summary:
Secure is our waste management business that operates primarily alongside the oil fields in Western Canada. This is a stable business whose cash flows are largely tied to oil production, which does not swing violently as oil drilling can. Accounting obscures true economics, but economic EBITDA margins are north of 30%. Management has been aggressively repurchasing shares and deploying capital into high-ROIC growth projects. Waste peers trade at materially higher multiples, while Secure trades around 10x EBITDA despite superior cash conversion.

BSD Analysis:
Secure Waste operates hazardous and industrial waste infrastructure where permitting is the real moat. Assets are scarce, regulated, and hard to replicate. Volume is tied to industrial activity and energy cycles. Pricing power exists locally, not universally. The failure mode is regulatory or operational incidents. The bull case is steady cash flow with limited competition. Secure Waste is infrastructure disguised as services. It compounds quietly when nothing goes wrong.

Pitch Summary:
NextNav is our wireless spectrum / terrestrial backup to GPS investment. Shares were more or less flat for the year, which of course did not help our performance. The only things that will matter for the success of the investment are getting FCC approval for NextNav’s plan, and what the re-purposed spectrum would be worth. NextNav has submitted a proposal for rulemaking to the FCC that would enable a terrestrial GPS-complement and backup system on the back of 5G mobile spectrum, requiring zero government funding. National security considerations, bipartisan political support, and FCC actions to date suggest the probability of approval is rising. If approved, the spectrum could be worth materially more than the current share price.

BSD Analysis:
NextNav provides vertical location data critical for emergency and urban navigation use cases. The moat is spectrum access and regulatory alignment, not consumer brand. Adoption depends on public safety mandates and ecosystem buy-in. Revenue visibility is limited today. The failure mode is slow adoption despite technical relevance. The bull case is regulatory-driven deployment at scale. NextNav is infrastructure optionality. Timing matters more than technology.

Pitch Summary:
Liquidia was first introduced anonymously in the YE’24 letter to LPs. At the time, the company was a pre-approval biopharmaceutical company that was mired in patent lawsuits filed by an incumbent that was seeking to defend their market position. Since that time, Liquidia’s drug – Yutrepia – has been approved for treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. Early sales of Yutrepia have crushed expectations as patients and prescribers seem to prefer Yutrepia versus the incumbent due to superior delivery and tolerability. Liquidia has won many patent battles already, but litigation continues with a resolution expected soon. If they win the patent battle, in my view the stock could easily double or triple as they continue to penetrate the market.

BSD Analysis:
Liquidia is a litigation-driven biotech with optionality tied to pulmonary hypertension products. The moat is IP positioning, not commercial scale—yet. Outcomes hinge on regulatory and legal decisions as much as science. Cash burn and timing risk dominate the equity. Commercial execution comes second to approval outcomes. The failure mode is delay plus dilution. The bull case is successful approval unlocking real revenue. Liquidia is binary until proven otherwise.

Pitch Summary:
Take for example our investment in Lifecore Biomedical, our CDMO that puts injectable drugs into syringes and vials. I have written about this investment extensively in the past, but in brief, Lifecore has excess capacity in a market where there is a global shortage of capacity, demand is growing, and new supply cannot be quickly or effectively built because of a limited supply chain and regulatory barriers. Additionally, customers shop on quality control above all else, and new facilities cannot demonstrate a long track record of effective quality control. It is nearly impossible to imagine scenarios where Lifecore does not fill their existing capacity absent completely destroying their ~40 year record of quality control, and incremental business is very sticky and comes with high margins. A new management team has been racking up customer wins and taking out costs. Private market value multiples suggest considerable upside for the stock, and a past sale process received low ball bids near the current stock price, suggesting downside protection is real.

BSD Analysis:
Lifecore is a contract manufacturer exposed to biotech funding cycles. The moat is technical capability and regulatory qualification, but customer concentration matters. Margins depend on utilization and mix. Execution issues show up quickly in cash flow. The failure mode is underutilized capacity plus leverage. The bull case is stabilized biotech demand and operational cleanup. Lifecore is a turnaround execution story. Balance sheet discipline decides survival.

Pitch Summary:
The Jacob Internet Fund added one new position in the quarter, Snowflake. Snowflake is a popular cloud-based platform that provides comprehensive data warehousing services, mainly for large businesses. By being cloud native, Snowflake helps companies more easily store, analyze and share their data across an entire organization, which has become a crucial ingredient for companies prioritizing IT infrastructure upgrades that can incorporate more AI functionality. A recently expanded partnership with Anthropic highlights how the company is quickly deepening its AI capabilities. Competition is fierce, but Snowflake has become the leading player in cloud data storage, especially for those companies looking for an agnostic solution that can support the multiple hyperscalers that many companies employ. Snowflake’s unique and dominant position in the data warehousing market, in what should be a high-growth profitable and sticky business over time, makes the company an attractive investment.

BSD Analysis:
Snowflake’s moat is data gravity and cross-cloud neutrality, not pricing power. Usage-based pricing aligns with value—but also with customer cost scrutiny. Growth slows quickly when customers optimize spend. Competition from hyperscalers is relentless and subsidized. Execution now matters more than vision. The failure mode is being squeezed between native cloud offerings and open-source alternatives. The bull case is expanding workloads and data applications. Snowflake must prove durability beyond early adopter enthusiasm.

Pitch Summary:
To end, we’ll talk about a new holding. I have followed the company closely since the IPO since my wife was an avid user, not wanting to “break her streak” in learning Italian. I thought growth would drop off a cliff after COVID as happened with many other companies, and yet, quarter after quarter the company continued to execute. In fact, there are only four companies I can find that have grown revenues greater than 30% for at least the last 20 quarters in a row – MercadoLibre, Axon, Hims, and Duolingo. The stock was down almost 70% after the valuation got far too rich and management made it very clear they were prioritizing learning over monetization for 2026. Duolingo shouldn’t be thought of as a language learning app, it’s an engagement machine that happens to educate. Almost 40% of monthly users log into the app every day. As the company broadens its education subjects like math, music, chess, and other areas, retention should increase even more. AI will allow the company to create better content and accelerate the platform’s expansion. We paid ~18x FCF, inclusive of stock-based comp.

BSD Analysis:
Duolingo’s moat is brand, engagement, and habit formation at massive scale. The product converts learning into a daily behavior, which is rare in education. Monetization is improving, but pricing power has limits. Content is defensible through data and iteration, not IP. The failure mode is engagement decay as novelty fades. Competition is abundant, but few achieve Duolingo’s retention. The bull case is expanding into broader education verticals. Duolingo is a consumer app masquerading as edtech.

Pitch Summary:
MercadoLibre will eventually encroach on Nu’s territory but there is so much whitespace in Mexico since much of the population is unbanked. This company’s management team is one of the few that actually thinks long-term. Lots of management teams give lip service to long-term decision making but this management team really does. They have outcompeted strong marketplaces like Amazon, Shopee, Temu and TikTokShop using vertical integration and fast delivery times. The e-commerce/payments flywheel is still spinning quite fast even at $25 billion in revenue.

BSD Analysis:
MercadoLibre is Latin America’s best platform business, combining commerce, payments, and logistics at scale. The moat is ecosystem density—buyers, sellers, payments, and delivery reinforce each other. Execution has been consistently strong, which is rare in volatile regions. FX and political risk are permanent features, not bugs. Credit exposure adds growth but raises risk. The failure mode is macro stress compressing margins and credit quality simultaneously. The bull case is continued ecosystem compounding. MELI earns its premium by surviving volatility better than peers.

Pitch Summary:
TransMedics has single-handedly changed the organ transplant process. In sticking with its mission to save lives, the company now owns 22 private jets and is doing roughly 30 organ transplants every single day. As density continues to grow, it becomes more difficult to compete with since the company’s cost per transplant decreases relative to competitors. The market size is the biggest risk here but if TransMedics continues to enable donor after circulatory death transplants, it will grow the entire market as fewer organs will be wasted.

BSD Analysis:
TransMedics is redefining organ transplantation logistics with its Organ Care System. The moat is clinical outcomes plus surgeon trust—both hard to displace once proven. Growth is driven by procedure expansion, not price hikes. Execution risk sits in scaling operations and logistics flawlessly. Competition exists, but switching costs are high once systems are standardized. The failure mode is operational missteps that undermine confidence. The bull case is structurally higher transplant utilization. TransMedics is a platform built on trust, not hype.

Pitch Summary:
Nu is gradually becoming a super app before our eyes. Its traction in Mexico after receiving the full banking license is evidence the model is replicable in geographies outside of Brazil. I believe there is a decent chance this company could become one of the biggest banks in the world as its lean cost structure enables better rates, which leads to more customers and economies of scale. Further, its success has come despite the terrible macro backdrop of Brazil over the past 15 years. Its battle-tested lending algorithms should withstand moving into more stable geographies over time.

BSD Analysis:
Nu is a category-defining fintech in Latin America with scale, brand trust, and low-cost distribution. The moat is customer acquisition efficiency paired with expanding product depth. Credit underwriting is the real swing factor—growth is easy, losses are expensive. Regulation and macro volatility are structural, not tail risks. Operating leverage is real once cohorts mature. The failure mode is credit deterioration hidden by growth optics. The bull case is durable multi-product penetration at scale. Nu is a great platform that must stay conservative to stay great.

Pitch Summary:
Renk Group AG is a German manufacturer of high-performance drive and transmission systems for defence and industrial markets.

BSD Analysis:
Renk is a high-quality defense supplier specializing in propulsion systems for armored vehicles and naval platforms. European rearmament has created multi-year demand visibility. Order books are expanding faster than capacity. Pricing power improves as governments prioritize delivery over cost. Margins benefit from scale and complexity. Investors underestimate how hard these systems are to replicate. Defense spending has structurally reset higher. Renk sits in a bottleneck segment. This is long-cycle defense growth with rare visibility.